NCT03483688
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
9,012 public trials
1,844 recruiting studies
Lymphatic Diseases trial results
Completed
IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
NCT01491841
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
NCT02296164
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Investigator Site Little Rock, Arkansas, United States
- Investigator Site Duarte, California, United States
- Investigator Site La Mesa, California, United States
- Investigator Site San Francisco, California, United States
Completed
Intrathecal Mafosfamide
NCT00062881
- Conditions
- Central Nervous System Neoplasms, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Children'sHospital Los Angeles Los Angeles, California, United States
- Children's Hospital National Medical Center Washington D.C., District of Columbia, United States
- Mayo Clinic Jacksonville, Florida, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
NCT01611090
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
- Locations
-
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Berkeley, California, United States
- Duarte, California, United States
NCT00372840
- Conditions
- Adenoma, Breast Cancer, Breast Diseases, +49 more
- Locations
-
- Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
NCT03106428
- Conditions
- Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +22 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Denver, Colorado, United States
- Research Site Atlanta, Georgia, United States
- Research Site Chicago, Illinois, United States
NCT00498316
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)
NCT02801578
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT01788189
- Conditions
- B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Klinik für Hämatologie, Universitätsklinikum Essen Essen, Germany